Srinagar, June 8 -- By Iffat Aurooj

A medical consensus published on May 12, 2026 in The Lancet replaced Polycystic Ovary Syndrome with a new term: Polyendocrine Metabolic Ovarian Syndrome.

Fourteen years of research, more than 50 professional bodies, and thousands of patient voices led to this change.

Nearly 170 million women live with this condition worldwide. The revision moves far beyond terminology. It corrects a long-standing scientific error that reduced a complex endocrine and metabolic disorder to a misleading label centered on ovarian cysts.

Language in medicine directs power, and medical naming decides which departments take responsibility, which budgets receive attention, and which patients gain serious clinical response....